The expanding field of immunotherapy relies heavily on recombinant cytokine technology, and a detailed understanding of individual profiles is absolutely crucial for optimizing experimental design and therapeutic efficacy. Specifically, examining the properties of recombinant IL-1A, IL-1B, IL-2, and IL-3 reveals notable differences in their molecul